Frontlight ResearchEarly access
Trial site
The Oncology Institute of Hope and Innovation
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/22 trials
- Phase 11 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Pfizer2 trials
- Daiichi Sankyo1 trial
- HUYABIO International, LLC.1 trial
- Nuvation Bio Inc.1 trial
Running trials
Active, not recruiting
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026